| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
30.42 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
3.37 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-7.72 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
1.2 |
% |
10.6019/CHEMBL4513141 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
19905.4 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
ATP-binding cassette sub-family C member 11 |
Activity |
76.0 |
% |
10.1124/mol.104.007138 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
564800.0 |
nM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Bile salt export pump |
IC50 |
586800.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Caco-2 |
logPapp |
-4.84 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.78 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
20.0 |
% |
10.1074/jbc.m110918200 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
110.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2003.09.007 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
nan |
None |
10.1124/mol.57.4.760 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Ki |
42200.0 |
nM |
10.2133/dmpk.17.23 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
10000.0 |
nM |
10.1016/j.bmc.2014.06.003 |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
10000.0 |
nM |
10.1016/j.bmc.2015.05.013 |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
10000.0 |
nM |
10.1016/j.bmc.2015.07.066 |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
431.0 |
nM |
10.1016/j.bmc.2014.06.003 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
431.0 |
nM |
10.1016/j.bmc.2015.05.013 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
431.0 |
nM |
10.1016/j.bmc.2015.07.066 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase IX |
Ki |
360.0 |
nM |
10.1016/j.bmc.2014.06.003 |
| Homo sapiens |
Carbonic anhydrase IX |
Ki |
360.0 |
nM |
10.1016/j.bmc.2015.05.013 |
| Homo sapiens |
Carbonic anhydrase IX |
Ki |
360.0 |
nM |
10.1016/j.bmc.2015.07.066 |
| Homo sapiens |
Carbonic anhydrase XII |
Ki |
1245.0 |
nM |
10.1016/j.bmc.2014.06.003 |
| Homo sapiens |
Carbonic anhydrase XII |
Ki |
1245.0 |
nM |
10.1016/j.bmc.2015.05.013 |
| Homo sapiens |
Carbonic anhydrase XII |
Ki |
1245.0 |
nM |
10.1016/j.bmc.2015.07.066 |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
63095.7 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
517.4 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
10.1124/dmd.110.035600 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-20.52 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-4.26 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
0.2 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
0.25 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
0.25 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.03 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.03 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Cmax |
123700.0 |
nM |
10.1021/acs.jmedchem.5b01091 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
6.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.01 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.99 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.13 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance associated protein |
Activity |
7.9 |
% |
None |
| Homo sapiens |
Multidrug resistance associated protein |
Activity |
nan |
None |
10.1074/jbc.m107041200 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1006/bbrc.1999.0671 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2003.09.007 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1021/jm900194w |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1124/mol.57.4.760 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Ratio IC50 |
1.4 |
None |
10.1021/jm900194w |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Ratio IC50 |
1.7 |
None |
10.1021/jm900194w |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Ratio IC50 |
1.9 |
None |
10.1021/jm900194w |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
10.0 |
% |
10.1681/asn.v133595 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
49.4 |
% |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
52.0 |
% |
10.1053/jhep.2003.50331 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Multidrug resistance-associated protein 5 |
Activity |
31.7 |
% |
10.1074/jbc.m005463200 |
| Homo sapiens |
Multidrug resistance-associated protein 6 |
Activity |
10.0 |
% |
10.1074/jbc.m110918200 |
| Homo sapiens |
Multidrug resistance-associated protein 6 |
Activity |
70.0 |
% |
10.1074/jbc.m110918200 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Pannexin-1 |
IC50 |
150000.0 |
nM |
10.1021/acs.jmedchem.5b01091 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1007/s00280-003-0745-2 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1023/a:1011076217118 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1038/sj.bjp.0706008 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Plasma |
fCmax |
35.04 |
uM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
-8.9 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Activity |
81.6 |
% |
10.1124/jpet.102.034330 |
| Homo sapiens |
Solute carrier family 22 member 11 |
IC50 |
25400.0 |
nM |
10.1254/jphs.94.197 |
| Homo sapiens |
Solute carrier family 22 member 11 |
IC50 |
54900.0 |
nM |
10.1016/j.ejmech.2019.01.043 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Inhibition |
81.4 |
% |
10.1124/dmd.112.048470 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Ki |
44400.0 |
nM |
10.1016/s0167-4889(02)00187-8 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Ki |
54900.0 |
nM |
10.1124/jpet.301.3.797 |
| Homo sapiens |
Solute carrier family 22 member 12 |
IC50 |
15000.0 |
nM |
10.1039/C6MD00190D |
| Homo sapiens |
Solute carrier family 22 member 12 |
IC50 |
50000.0 |
nM |
10.1124/dmd.106.012187 |
| Homo sapiens |
Solute carrier family 22 member 12 |
IC50 |
86390.0 |
nM |
10.1021/jm1015022 |
| Homo sapiens |
Solute carrier family 22 member 12 |
IC50 |
174000.0 |
nM |
None |
| Homo sapiens |
Solute carrier family 22 member 12 |
Inhibition |
30.0 |
% |
10.1124/dmd.106.012187 |
| Homo sapiens |
Solute carrier family 22 member 12 |
Inhibition |
35.7 |
% |
10.1021/jm1015022 |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
77.4 |
% |
None |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
9.2 |
% |
10.1046/j.1523-1755.2003.00710.x |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
52.1 |
% |
10.1124/jpet.102.034330 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1006/bbrc.1998.9978 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1152/ajprenal.1999.276.2.f295 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
6300.0 |
nM |
10.1006/abio.2000.4633 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
7400.0 |
nM |
None |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
12100.0 |
nM |
10.1016/j.ejmech.2019.01.043 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
12300.0 |
nM |
10.1254/jphs.94.197 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
12500.0 |
nM |
10.1046/j.1523-1755.2003.00710.x |
| Homo sapiens |
Solute carrier family 22 member 6 |
Inhibition |
96.2 |
% |
10.1124/dmd.112.048470 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
4300.0 |
nM |
10.1006/abio.2000.4633 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
4410.0 |
nM |
10.1016/s0024-3205(01)01296-6 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
12100.0 |
nM |
10.1016/s0014-2999(01)00962-1 |
| Homo sapiens |
Solute carrier family 22 member 7 |
IC50 |
668000.0 |
nM |
10.1254/jphs.94.197 |
| Homo sapiens |
Solute carrier family 22 member 7 |
Ki |
766000.0 |
nM |
10.1124/jpet.301.3.797 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1124/mol.59.5.1277 |
| Homo sapiens |
Solute carrier family 22 member 8 |
IC50 |
4930.0 |
nM |
10.1254/jphs.94.197 |
| Homo sapiens |
Solute carrier family 22 member 8 |
IC50 |
9000.0 |
nM |
10.1016/j.ejmech.2019.01.043 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Inhibition |
88.5 |
% |
10.1124/dmd.112.048470 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
4410.0 |
nM |
10.1016/s0024-3205(01)01296-6 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
9000.0 |
nM |
10.1016/s0014-2999(01)00962-1 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
29800.0 |
nM |
10.1124/jpet.102.034330 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
35.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
81.99 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
22.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
89.44 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
26.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Survival motor neuron protein |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Transient receptor potential cation channel subfamily A member 1 |
Activity |
nan |
None |
10.1016/j.ejmech.2019.02.074 |
| Homo sapiens |
Transient receptor potential cation channel subfamily A member 1 |
EC50 |
4200000.0 |
nM |
10.1016/j.ejmech.2019.02.074 |
| Homo sapiens |
Transient receptor potential cation channel subfamily A member 1 |
pEC50 |
nan |
None |
10.1016/j.ejmech.2019.02.074 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Ki |
221000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-10 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-10 |
Ki |
231000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Ki |
1429000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-7 |
Ki |
96000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-8 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Ki |
2452000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
1.4 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
16.52 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Pannexin-1 |
IC50 |
150000.0 |
nM |
10.1016/j.ejmech.2021.113650 |
| Mus musculus |
Putative organic anion transporter 5 |
Activity |
25.0 |
% |
10.1152/ajprenal.00012.2004 |
| Mus musculus |
Solute carrier family 22 member 20 |
Ki |
8400.0 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 20 |
Ki |
8511.38 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1074/jbc.274.3.1519 |
| Mus musculus |
Solute carrier family 22 member 6 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 6 |
Ki |
6309.57 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 6 |
Ki |
6400.0 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
0.625 |
% |
10.1124/jpet.103.063370 |
| Mus musculus |
Solute carrier family 22 member 8 |
IC50 |
3020.0 |
nM |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier organic anion transporter family member 1C1 |
Ki |
293000.0 |
nM |
10.1210/en.2004-0058 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Pan troglodytes |
Pan troglodytes |
Excretion rate |
nan |
None |
10.1021/jm00139a020 |
| Pan troglodytes |
Pan troglodytes |
Ratio |
0.05 |
None |
10.1021/jm00203a006 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.12 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.2 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.57 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.64 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.78 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
0.83 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
1.02 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
1.12 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
1.2 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
1.21 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
1.57 |
nM |
10.1128/aac.01689-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
FICI |
5.9 |
nM |
10.1128/aac.01689-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
19.93 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Bile acid transporter |
Activity |
nan |
None |
10.1073/pnas.88.23.10629 |
| Rattus norvegicus |
Bile salt export pump |
IC50 |
509900.0 |
nM |
10.1124/dmd.111.040758 |
| Rattus norvegicus |
Canalicular multispecific organic anion transporter 1 |
Activity |
nan |
None |
10.1023/a:1022238506509 |
| Rattus norvegicus |
Canalicular multispecific organic anion transporter 1 |
Activity |
nan |
None |
10.1124/jpet.102.044107 |
| Rattus norvegicus |
Canalicular multispecific organic anion transporter 1 |
Ki |
44600.0 |
nM |
10.2133/dmpk.17.23 |
| Rattus norvegicus |
Canalicular multispecific organic anion transporter 2 |
Activity |
nan |
None |
10.1124/jpet.102.044107 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Monocarboxylate transporter 1 |
Activity |
110.0 |
% |
10.1042/0264-6021:3410529 |
| Rattus norvegicus |
Monocarboxylate transporter 2 |
Activity |
88.0 |
% |
10.1042/0264-6021:3410529 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.13 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm00203a006 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
404.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
404.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
531.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
534.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
55.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
70.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
70.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
83.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
96.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
114.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
110.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
136.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
203.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
553.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
580.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
633.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
810.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
196.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
599.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
902.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
910.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
29670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
31000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
33670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.9 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
58.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
106.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
118.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
143.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1556.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1573.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1690.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1780.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.07 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.9 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.2 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
134000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
135000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
137000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
143300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
142.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
213.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
259.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
364.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12848.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13997.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
14409.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15278.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
86.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
91.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.93 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.67 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.03 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.73 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
396000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
397300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
406000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.4 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.8 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.93 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.43 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
53.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
58.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
137.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
272.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
6.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
12.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
894.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1155.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1476.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2126.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
103.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
108.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
109.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
111.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1072330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1128330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1182330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1224330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.85 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.4 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.49 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
51300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
54300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
55300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5200000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5430000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5570000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6000000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
139.6 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.87 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.7 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
14.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
16.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14130.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
15430.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
16700.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
16870.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
IC50 |
1640000.0 |
nM |
10.1152/ajprenal.2001.281.3.f454 |
| Rattus norvegicus |
Solute carrier family 22 member 2 |
IC50 |
1700000.0 |
nM |
10.1152/ajprenal.2001.281.3.f454 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1046/j.1523-1755.1999.00789.x |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Ki |
15800.0 |
nM |
10.1016/s0014-2999(00)00837-2 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Ki |
31000.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier family 22 member 7 |
IC50 |
977000.0 |
nM |
10.1254/jphs.94.197 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Activity |
23.4 |
% |
10.1097/00004647-200304000-00007 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1074/jbc.274.19.13675 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
IC50 |
6030.0 |
nM |
10.1254/jphs.94.197 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Ki |
4430.0 |
nM |
10.1124/mol.61.5.982 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Ki |
20000.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A1 |
Inhibition |
74.0 |
% |
10.1016/0270-9139(94)90194-5 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A1 |
Ki |
74400.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A4 |
Ki |
72900.0 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.12 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.35 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.2093 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
13.34 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jnatprod.8b00888 |
| None |
ADMET |
CL |
0.25 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
0.9 |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
MRT |
8.7 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
PPB |
83.0 |
% |
10.1016/j.ejmech.2019.01.043 |
| None |
ADMET |
T1/2 |
4.0 |
hr |
10.1016/j.ejmech.2019.01.043 |
| None |
ADMET |
T1/2 |
5.9 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Tmax |
1.0 |
hr |
10.1016/j.ejmech.2019.01.043 |
| None |
ADMET |
Vdss |
0.13 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.13 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Ratio |
0.05 |
None |
10.1021/jm00139a020 |
| None |
No relevant target |
LogD |
0.11 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD7.4 |
0.03 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Log Kmemb |
-3.1 |
None |
10.1021/jm0309001 |
| None |
No relevant target |
LogP |
-0.019 |
None |
10.1007/s00044-009-9162-3 |
| None |
No relevant target |
pKa |
3.01 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
3.4 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKa_A1 |
3.36 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
3.9 |
ug.mL-1 |
10.1016/j.bmc.2010.08.003 |
| None |
No relevant target |
T1/2 |
0.27 |
hr |
10.1021/acs.jmedchem.9b00917 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
0.2818 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.122 |
uM |
None |
| None |
Unchecked |
Ac50 |
4.467 |
uM |
None |
| None |
Unchecked |
Ac50 |
5.623 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.079 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.943 |
uM |
None |
| None |
Unchecked |
AC50 |
281.8 |
nM |
None |
| None |
Unchecked |
AC50 |
1122.0 |
nM |
None |
| None |
Unchecked |
AC50 |
4470.0 |
nM |
None |
| None |
Unchecked |
AC50 |
5623.4 |
nM |
None |
| None |
Unchecked |
AC50 |
7079.5 |
nM |
None |
| None |
Unchecked |
AC50 |
7943.3 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm900194w |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
100000.0 |
nM |
10.1021/acs.jmedchem.5b01091 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
1100000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| None |
Unchecked |
Ki |
1600000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
730.8 |
nM |
None |
| None |
Unchecked |
Ratio pKi |
-0.12 |
None |
10.1074/jbc.m703467200 |